Hologic and Inpeco Partner for European Lab Automation
The collaboration integrates molecular diagnostics with automated systems to boost laboratory throughput.
Updated on Oct. 20, 2026 in Healthcare
Live Poll
Do you believe partnerships between lab equipment companies help improve the reliability of diagnostic test results?
Hologic and Inpeco have announced a co-marketing partnership in Europe to streamline molecular diagnostics. The agreement combines Inpeco's FlexLab X automation system with Hologic's Panther System.
Why it matters
The partnership addresses the growing need for laboratories to manage increasing test volumes and complexity. By automating diagnostic workflows, the deal seeks to improve efficiency in high-throughput testing environments.
Inpeco has established a significant operational footprint with 2,800 systems currently shipped across 78 countries. This partnership aims to leverage that installed base to integrate the Panther molecular diagnostics platform.
The players
Hologic
Hologic is an American medical technology company primarily focused on women's health and molecular diagnostics.
Inpeco
Inpeco is a Swiss manufacturer headquartered in Novazzano that specializes in total laboratory automation solutions.
The details
The FlexLab X system connects multiple Hologic Panther units into a single automated diagnostic workflow. This integration enables laboratories to scale their molecular testing capabilities while minimizing manual intervention.
Timeline
October 20, 2026: Hologic and Inpeco announced their co-marketing partnership.
Market Landscape
This move reflects a broader trend of cross-firm integration to solve complex workflow bottlenecks in clinical pathology. It positions the companies to better compete against single-vendor diagnostic platforms by offering modular automation interoperability.
Laboratories in Europe may see improvements in testing turnaround times as these automated systems are deployed. This transition could eventually lead to more rapid delivery of patient diagnostic results for hospitals and clinics.
The takeaway
Laboratories must increasingly adopt integrated systems to handle the rising complexity of molecular diagnostic testing. Investing in interoperable automation technology allows facilities to scale capacity without a proportional increase in manual labor.
Further reading
Learn more about the latest innovations in diagnostic infrastructure on the Healthcare page.
Live Poll
Do you believe partnerships between lab equipment companies help improve the reliability of diagnostic test results?
